Cargando…

Quality of life effects of antithrombin III in sepsis survivors: results from the KyberSept trial [ISRCTN22931023]

INTRODUCTION: Treatment of sepsis is aimed at increasing both the duration and quality of survival. A long-term focus on quality of life (QoL) in clinical trial evaluations of sepsis care should be a priority. METHOD: QoL data were used to evaluate the effects of intravenous antithrombin III treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Rublee, Dale, Opal, Steven M, Schramm, Wolfgang, Keinecke, Heinz-Otto, Knaub, Sigurd
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC125322/
https://www.ncbi.nlm.nih.gov/pubmed/12225612